Cargando…
Mitochondria-targeted inhibitors of the human SIRT3 lysine deacetylase
Sirtuin 3 (SIRT3) is the major protein lysine deacetylase in the mitochondria. This hydrolase regulates a wide range of metabolically involved enzymes and has been considered as a potential drug target in certain cancers. Investigation of pharmacological intervention has been challenging due to a la...
Autores principales: | Troelsen, Kathrin S., Bæk, Michael, Nielsen, Alexander L., Madsen, Andreas S., Rajabi, Nima, Olsen, Christian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341665/ https://www.ncbi.nlm.nih.gov/pubmed/34458804 http://dx.doi.org/10.1039/d0cb00216j |
Ejemplares similares
-
Mechanism-based inhibitors of SIRT2: structure–activity relationship, X-ray structures, target engagement, regulation of α-tubulin acetylation and inhibition of breast cancer cell migration
por: Nielsen, Alexander L., et al.
Publicado: (2021) -
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase
por: Bolding, Julie E., et al.
Publicado: (2022) -
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme
por: Rajabi, Nima, et al.
Publicado: (2022) -
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
por: Moreno-Yruela, Carlos, et al.
Publicado: (2022) -
Targeting Lysine Deacetylases (KDACs) in Parasites
por: Wang, Qi, et al.
Publicado: (2015)